DIANE BIELEFELD: Open Payments
NPI 1609183862 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,506 in 50 payments from 18 companies in 2025. Trend: 2023 $1,482 · 2024 $2,354 · 2025 $1,506
Food & beverage: $1,506
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $250 |
| Medtronic, Inc. | 4 | $178 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $134 |
| ABBVIE INC. | 1 | $125 |
| EVOKE PHARMA, INC. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $120 |
| ABIOMED | 1 | $94 |
| Merck Sharp & Dohme LLC | 4 | $87 |
| Amgen Inc. | 3 | $73 |
| E.R. Squibb & Sons, L.L.C. | 3 | $70 |
Products named: LEQVIO, COREVALVE EVOLUT R, Kerendia, MAVYRET, GIMOTI, Auvelity, ELIQUIS, REPATHA.
Industry payments across KY — which companies pay providers there.
